Trusted News Discovery Since 2008
{{/content}}
'COVAXIN' demonstrated efficacy of 80.6% in Phase 3 clinical trial: Bharat Biotech
Video Credit: ANI
Published on March 3, 2021 - Duration: 01:42s
'COVAXIN' demonstrated efficacy of 80.6% in Phase 3 clinical trial: Bharat Biotech
Bharat Biotech's COVID-19 vaccine, 'COVAXIN' has demonstrated an interim vaccine efficacy of 80.6% in its Phase 3 clinical trial.
"Today is an important day for us, country and Indian science.
COVAXIN has demonstrated an interim vaccine efficacy of around 80.6% in its Phase 3 clinical trial.
The trials involved 25,800 subjects, the largest ever conducted in India, in partnership with ICMR," Bharat Biotech chairman Dr Krishna Ella.
You are here
💡 newsR Knowledge: Other News Mentions
BBV152
Vaccine against COVID-19
The PM’s directive came at a review meeting on the Covid situation on Saturday a day after he had overseen an assessment of oxygen supplies and production and..
Credit: IndiaTimes - Published 10 hours ago
Union health minister Harsh Vardhan said financial support is being provided to four manufacturers to expand Covaxin vaccine production.
Credit: DNA - Published 2 days ago
The Union government on Friday said it will amp up the production of the indigenously developed Covaxin vaccine to 100 million doses per month by September. As..
Credit: IndiaTimes - Published 2 days ago
COVID-19
Disease caused by severe acute respiratory syndrome coronavirus 2
Credit: IndiaTimes - Published 8 minutes ago
Congress leader Rahul Gandhi on Sunday suspended his campaign for the West Bengal assembly elections owing to the prevailing Covid-19 situation in the country.
Credit: IndiaTimes - Published 8 minutes ago
India on Sunday recorded another highest-ever spike of 2,61,500 coronavirus infections, taking its total Covid-19 cases tally to 1,47,88,109. India also reported..
Credit: IndiaTimes - Published 1 hour ago
Credit: IndiaTimes - Published 2 hours ago
Bharat Biotech
Indian biotechnology company and vaccine manufacturer
Indications are that India’s vaccine production is expected to be limited for a few more weeks though a step-up is expected as Serum Institute of India and..
Credit: IndiaTimes - Published 1 week ago
Indian Council of Medical Research
Government Organization
Related news from verified sources
Bharat Biotech announced the phase 3 results of its coronavirus vaccine ‘Covaxin’on Wednesday claiming the shots have demonstrated an interim clinical...
on March 3, 2021 • Zee News
prestigious medical journal The Lancet has now published Phase 2 clinical trial results of Bharat Biotech's Covaxin. "Due to the difference in dosing regimens...
on March 9, 2021 • IndiaTimes
Related videos from verified sources
Nurses share experience after administering COVID vaccine to PM Modi 01:16
Video credit: ANI - Published 1 week ago
Phase 3 Clinical Trial Of Pfizer Covid-19 Vaccine Remains Highly Effective After Six Months 02:26
Video credit: CBS4 Miami - Published 2 weeks ago
Pfizer Says COVID-19 Vaccine Protection Lasts at Least 6 Months 01:00
Video credit: Cover Video STUDIO - Published 2 weeks ago